120 related articles for article (PubMed ID: 29535812)
1. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.
Mihailidou C; Papakotoulas P; Papavassiliou AG; Karamouzis MV
Oncotarget; 2018 Feb; 9(12):10360-10374. PubMed ID: 29535812
[TBL] [Abstract][Full Text] [Related]
2. The antitumor activity of the fungicide ciclopirox.
Zhou H; Shen T; Luo Y; Liu L; Chen W; Xu B; Han X; Pang J; Rivera CA; Huang S
Int J Cancer; 2010 Nov; 127(10):2467-77. PubMed ID: 20225320
[TBL] [Abstract][Full Text] [Related]
3. Ciclopirox Olamine Exerts Tumor-Suppressor Effects
Yin J; Che G; Jiang K; Zhou Z; Wu L; Xu M; Liu J; Yan S
Front Oncol; 2022; 12():791916. PubMed ID: 35251970
[TBL] [Abstract][Full Text] [Related]
4. CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer.
Zhou J; Zhang L; Wang M; Zhou L; Feng X; Yu L; Lan J; Gao W; Zhang C; Bu Y; Huang C; Zhang H; Lei Y
Theranostics; 2019; 9(19):5577-5594. PubMed ID: 31534504
[No Abstract] [Full Text] [Related]
5. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.
Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z
PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale.
Carmo PHF; Freitas GJC; Dornelas JCM; Almeida BCT; Baltazar LM; Ferreira GF; Peres NTA; Santos DA
Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35896502
[TBL] [Abstract][Full Text] [Related]
7. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
Eberhard Y; McDermott SP; Wang X; Gronda M; Venugopal A; Wood TE; Hurren R; Datti A; Batey RA; Wrana J; Antholine WE; Dick JE; Schimmer AD
Blood; 2009 Oct; 114(14):3064-73. PubMed ID: 19589922
[TBL] [Abstract][Full Text] [Related]
8. Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome.
Dihazi GH; Bibi A; Jahn O; Nolte J; Mueller GA; Engel W; Dihazi H
World J Stem Cells; 2013 Jan; 5(1):9-25. PubMed ID: 23362436
[TBL] [Abstract][Full Text] [Related]
9. Ciclopirox Olamine Induces Proliferation Inhibition and Protective Autophagy in Hepatocellular Carcinoma.
Wan X; Xiang J; Fan H; Jiang Y; Lu Y; Zhang C; Zhang Y; Chen Q; Lei Y
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678610
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs.
Weir SJ; Wood R; Schorno K; Brinker AE; Ramamoorthy P; Heppert K; Rajewski L; Tanol M; Ham T; McKenna MJ; McCulloch W; Dalton M; Reed GA; Jensen RA; Baltezor MJ; Anant S; Taylor JA
J Pharmacol Exp Ther; 2019 Aug; 370(2):148-159. PubMed ID: 31113837
[TBL] [Abstract][Full Text] [Related]
11. Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex.
Weir SJ; Dandawate P; Standing D; Bhattacharyya S; Ramamoorthy P; Rangarajan P; Wood R; Brinker AE; Woolbright BL; Tanol M; Ham T; McCulloch W; Dalton M; Reed GA; Baltezor MJ; Jensen RA; Taylor JA; Anant S
Cell Death Dis; 2021 May; 12(6):562. PubMed ID: 34059639
[TBL] [Abstract][Full Text] [Related]
12. ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy.
Fan H; He Y; Xiang J; Zhou J; Wan X; You J; Du K; Li Y; Cui L; Wang Y; Zhang C; Bu Y; Lei Y
Redox Biol; 2022 Jul; 53():102339. PubMed ID: 35636017
[TBL] [Abstract][Full Text] [Related]
13. In vitro model of infected stratum corneum for the efficacy evaluation of poloxamer 407-based formulations of ciclopirox olamine against Trichophyton rubrum as well as differential scanning calorimetry and stability studies.
Täuber A; Müller-Goymann CC
Int J Pharm; 2015 Oct; 494(1):304-11. PubMed ID: 26276254
[TBL] [Abstract][Full Text] [Related]
14. Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells.
Chen L; Chen D; Li J; He L; Chen T; Song D; Shan S; Wang J; Lu X; Lu B
Cell Death Dis; 2022 Nov; 13(11):1007. PubMed ID: 36443287
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells.
Nambiar D; Prajapati V; Agarwal R; Singh RP
Cancer Lett; 2013 Jun; 334(1):109-17. PubMed ID: 23022268
[TBL] [Abstract][Full Text] [Related]
16. The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis.
Linden T; Katschinski DM; Eckhardt K; Scheid A; Pagel H; Wenger RH
FASEB J; 2003 Apr; 17(6):761-3. PubMed ID: 12594177
[TBL] [Abstract][Full Text] [Related]
17. Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer.
Chen Y; Guo Q; Zhang B; Kang M; Xie Q; Wu Y
Oncol Lett; 2012 Oct; 4(4):792-798. PubMed ID: 23205102
[TBL] [Abstract][Full Text] [Related]
18. Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A.
Shen T; Shang C; Zhou H; Luo Y; Barzegar M; Odaka Y; Wu Y; Huang S
Genes Cancer; 2017 Mar; 8(3-4):505-516. PubMed ID: 28680535
[TBL] [Abstract][Full Text] [Related]
19. Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.
Minden MD; Hogge DE; Weir SJ; Kasper J; Webster DA; Patton L; Jitkova Y; Hurren R; Gronda M; Goard CA; Rajewski LG; Haslam JL; Heppert KE; Schorno K; Chang H; Brandwein JM; Gupta V; Schuh AC; Trudel S; Yee KW; Reed GA; Schimmer AD
Am J Hematol; 2014 Apr; 89(4):363-8. PubMed ID: 24273151
[TBL] [Abstract][Full Text] [Related]
20. Repurposing antimycotic ciclopirox olamine as a promising anti-ischemic stroke agent.
Feng H; Hu L; Zhu H; Tao L; Wu L; Zhao Q; Gao Y; Gong Q; Mao F; Li X; Zhou H; Li J; Zhang H
Acta Pharm Sin B; 2020 Mar; 10(3):434-446. PubMed ID: 32140390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
